News | Radiation Therapy | October 16, 2017

Integration of Versa HD linear accelerator and ExacTrac empowers clinicians to optimize radiation therapy inside and outside the brain

Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy

October 16, 2017 — Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator and Brainlab ExacTrac patient positioning and monitoring technology. The integration of these two technologies offers high-definition stereotactic radiosurgery (HDRS) treatments with versatile patient positioning and monitoring through simplified workflows. A Versa HD system augmented with ExacTrac was displayed at the Elekta booth during the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 24-27 in San Diego.

The number of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) procedures is expected to increase dramatically between 2014 and 2024 (70 percent and 103 percent, respectively). This growth is substantially larger than the estimated increase in the number of patients estimated for these treatments (22 percent and 26 percent, respectively), reflecting the wider adoption of stereotactic radiation to treat intra- as well as extra-cranial tumors. Innovative workflows that address the challenges associated with using these procedures for different anatomies are essential to ensuring a high degree of safety, efficacy and efficiency.

In line with the growing adoption of radiosurgery, the Versa HD HDRS and ExacTrac solution will provide clinicians the following benefits:

  • Support the delivery of high-definition stereotactic treatments in standard treatment slots, regardless of tumor complexity or anatomy;
  • Frameless stereotactic solutions for multiple anatomical applications; and
  • Integrated workflows and robust image guidance and motion management during delivery for coplanar and non-coplanar treatments.

Ludwig-Maximilian University (LMU) Hospital in Munich has used the integrated system for more than two years. “The integration of Versa HD and ExacTrac enables a seamless workflow that allows us to improve patient comfort while reducing treatment time,” said Prof. Claus Belka, M.D., director, Department of Radiation Oncology at LMU. “Combined, these technologies give us the flexibility to treat complex tumors that require extremely precise targeting using the same systems with which we treat more conventional cases. This helps us to reduce the cost of delivering quality care to all of our patients.”

In September 2016, Elekta and Brainlab announced an agreement designed to ensure the continuous evolution of interoperability and safety of Elekta’s Leksell Vantage Stereotactic System and Elements Stereotaxy treatment planning and verification software from Brainlab. The integrated use of both systems is designed to improve the safety and accuracy of stereotactic neurosurgical procedures. In June 2017, the companies announced that Brainlab would be the authorized distributor of Elekta’s stereotactic solutions for neurosurgery in selected markets.

For more information: www.elekta.com, www.brainlab.com


Related Content

News | Radiation Therapy

May 16, 2024 — Today marks a significant milestone in cancer care with the introduction of bipartisan federal ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
Subscribe Now